Search

Author/Creator Varma, Manthena V. S.

1. Biomarker‐Informed Model‐Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug‐Drug Interactions. Issue 2 (22nd October 2021)

Authors:
Kimoto, Emi; Costales, Chester; West, Mark A.; Bi, Yi‐an; Vourvahis, Manoli; David Rodrigues, A.; Varma, Manthena V. S.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 111:Issue 2(2022)
Page Start:
404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. Issue 3 (21st June 2022)

Authors:
Chu, Xiaoyan; Prasad, Bhagwat; Neuhoff, Sibylle; Yoshida, Kenta; Leeder, James Steven; Mukherjee, Dwaipayan; Taskar, Kunal; Varma, Manthena V. S.; Zhang, Xinyuan; Yang, Xinning; Galetin, Aleksandra
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 3(2022)
Page Start:
501
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug. Issue 3 (9th May 2022)

Authors:
Tess, David A.; Kimoto, Emi; King‐Ahmad, Amanda; Vourvahis, Manoli; Rodrigues, A. David; Bergman, Arthur; Qui, Ruolun; Somayaji, Veena; Weng, Yan; Fonseca, Kari R.; Litchfield, John; Varma, Manthena V. S.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 3(2022)
Page Start:
605
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of Hepatic Impairment on OATP1B Activity: Quantitative Pharmacokinetic Analysis of Endogenous Biomarker and Substrate Drugs. Issue 5 (15th January 2023)

Authors:
Lin, Jian; Kimoto, Emi; Yamazaki, Shinji; Vourvahis, Manoli; Bergman, Arthur; Rodrigues, A. David; Costales, Chester; Li, Rui; Varma, Manthena V. S.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 113:Issue 5(2023)
Page Start:
1058
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Quantitative prediction of breast cancer resistant protein mediated drug‐drug interactions using physiologically‐based pharmacokinetic modeling. (20th July 2021)

Authors:
Costales, Chester; Lin, Jian; Kimoto, Emi; Yamazaki, Shinji; Gosset, James R.; Rodrigues, A. David; Lazzaro, Sarah; West, Mark A.; West, Michael; Varma, Manthena V. S.
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 10:Number 9(2021)
Page Start:
1018
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance. Issue 3 (29th June 2022)

Authors:
Zamek‐Gliszczynski, Maciej J.; Sangha, Vishal; Shen, Hong; Feng, Bo; Wittwer, Matthias B.; Varma, Manthena V. S.; Liang, Xiaomin; Sugiyama, Yuichi; Zhang, Lei; Bendayan, Reina
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 3(2022)
Page Start:
485
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗